Clinical trial
Effect of Balloon Angioplasty vs Stenting Following Residual Stenosis After Endovascular Treatment of Intracranial Atherosclerotic Acute Ischemic Stroke: A Multicenter, Prospective, Open-label, Endpoint-blinded, Randomized Controlled Study
NCT07026331 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Balloon Angioplasty vs Stenting Following Residual Stenosis After Endovascular Treatment of Intracranial Atherosclerotic Acute Ischemic Stroke: A Multicenter, Prospective, Open-label, Endpoint-blinded, Randomized Controlled Study
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 3, 2025
- Completion date
- July 1, 2027
- Enrollment
- 486 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke, intracranial atherosclerosis icas